| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/19/1999 | WO1999041378A1 Members of the d52 gene family |
| 08/19/1999 | WO1999041377A1 Novel cystine knot protein and materials and methods for making it |
| 08/19/1999 | WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | WO1999041374A2 Human short-chain tnf-receptor family protein |
| 08/19/1999 | WO1999041373A2 Human transport-associated molecules |
| 08/19/1999 | WO1999041369A2 Genetic vaccine vector engineering |
| 08/19/1999 | WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines |
| 08/19/1999 | WO1999041364A2 Compositions and methods for wound healing |
| 08/19/1999 | WO1999041360A1 Method for the development of an hiv vaccine |
| 08/19/1999 | WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
| 08/19/1999 | WO1999040924A2 Treatment of neurodegeneration |
| 08/19/1999 | WO1999040909A1 Method for modulating macrophage activation |
| 08/19/1999 | WO1999040793A1 C3a serum-free clonal cell line and methods of use |
| 08/19/1999 | WO1999040783A1 Method of controlling proliferation and differentiation of stem and progenitor cells |
| 08/19/1999 | WO1999036432A3 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
| 08/19/1999 | WO1999033998A3 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
| 08/19/1999 | WO1999031255A3 Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes |
| 08/19/1999 | WO1999029871A3 Circovirus sequences related to piglet weight loss disease (pwd) |
| 08/19/1999 | WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof |
| 08/19/1999 | WO1999024058A3 Neuronal uses of bmp-11 |
| 08/19/1999 | WO1999023236A9 Method of dna shuffling |
| 08/19/1999 | CA2632106A1 Method for modulating macrophage activation |
| 08/19/1999 | CA2323011A1 Method for the development of an hiv vaccine |
| 08/19/1999 | CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/19/1999 | CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | CA2321105A1 Human short-chain tnf-receptor family protein |
| 08/19/1999 | CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines |
| 08/19/1999 | CA2320806A1 Members of the d52 gene family |
| 08/19/1999 | CA2320784A1 Members of the d52 gene family |
| 08/19/1999 | CA2320626A1 Genetic vaccine vector engineering |
| 08/19/1999 | CA2320513A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors |
| 08/19/1999 | CA2320431A1 Targeting of genetic vaccine vectors |
| 08/19/1999 | CA2320424A1 Human transport-associated molecules |
| 08/19/1999 | CA2320422A1 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
| 08/19/1999 | CA2320420A1 Promoter inductible in plants, sequence incorporating same and resulting product |
| 08/19/1999 | CA2320401A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase |
| 08/19/1999 | CA2320391A1 Novel cystine knot protein and materials and methods for making it |
| 08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
| 08/19/1999 | CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | CA2319212A1 Methods for purified aav vector production |
| 08/19/1999 | CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 08/19/1999 | CA2318737A1 Methods for pseudoadenoviral vector production |
| 08/19/1999 | CA2312991A1 Prostate-associated serine protease |
| 08/18/1999 | EP0936270A2 Serin protease from prostate |
| 08/18/1999 | EP0935676A2 Method of identifying cytochrome p450 |
| 08/18/1999 | EP0935666A1 Methods for altering the rate of plant development and plants obtained therefrom |
| 08/18/1999 | EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists |
| 08/18/1999 | EP0935661A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 08/18/1999 | EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 08/18/1999 | EP0935658A1 Genetic control of flowering |
| 08/18/1999 | EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
| 08/18/1999 | EP0935656A1 Hedgehog interacting proteins and uses related thereto |
| 08/18/1999 | EP0935655A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 08/18/1999 | EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 08/18/1999 | EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 08/18/1999 | EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY |
| 08/18/1999 | EP0935649A1 Artificial rheumatic pannus tissues and diagnostic method for detecting rheumatoid arthritis |
| 08/18/1999 | EP0935648A1 Improved adenovirus vectors |
| 08/18/1999 | EP0935610A1 Novel human interferon-inducible protein |
| 08/18/1999 | EP0935471A1 Mononuclear phagocytes in therapeutic drug delivery |
| 08/18/1999 | EP0935466A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/18/1999 | EP0935458A1 Compositions containing at least one nucleic acid |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | EP0822978A4 Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native vascular grafts |
| 08/18/1999 | EP0703978B1 Medium for long-term proliferation and development of cells |
| 08/18/1999 | EP0652895B1 Compounds which inhibit hiv replication |
| 08/18/1999 | EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 08/18/1999 | EP0584267B1 Tumor associated monoclonal antibody 81av78 |
| 08/18/1999 | CN1226285A Gene expression regulatory DNA, expression cassette and expression vector and transgenic plant |
| 08/18/1999 | CN1225945A DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/17/1999 | US5939598 Method of making transgenic mice lacking endogenous heavy chains |
| 08/17/1999 | US5939540 Platelet secretory transport protein |
| 08/17/1999 | US5939539 GA 20-oxidase gene sequences |
| 08/17/1999 | US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 08/17/1999 | US5939383 Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same |
| 08/17/1999 | US5939323 Dissolving water-insoluble ester of hyaluonic acid in first solvent, mixing with pore forming agent, adding second solvent to extract first solvent and pore forming agent, drying formed scaffold under vaccum |
| 08/17/1999 | US5939314 Distributed pore chemistry in porous organic polymers in tissue culture flasks |
| 08/17/1999 | US5939302 IKK-β proteins, nucleic acids and methods |
| 08/17/1999 | US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds |
| 08/17/1999 | US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them |
| 08/17/1999 | US5939284 Protein phosphatase 1 binding protein, R5 |
| 08/17/1999 | US5939280 Immunological assay for quantifying peg-modified human granulocyte colony stimulating factor and monoclonal antibodies used in the assay |
| 08/17/1999 | US5939274 Immunological binding antibodies or fragments capable of specifically binding to peptide fragment derived from bone collagen |
| 08/17/1999 | US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens |
| 08/17/1999 | US5939263 Neuropeptide Y receptor |
| 08/17/1999 | US5939073 Fish pancreatic disease virus |
| 08/17/1999 | US5939068 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 08/12/1999 | WO1999040225A1 Immediate early genes and methods of use therefor |
| 08/12/1999 | WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA |
| 08/12/1999 | WO1999040201A1 Protein |
| 08/12/1999 | WO1999040199A2 A novel fungal protein critical for expression of fungal proteins |
| 08/12/1999 | WO1999040197A2 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf |
| 08/12/1999 | WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 08/12/1999 | WO1999040192A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14 |
| 08/12/1999 | WO1999040189A2 Cdnas encoding secreted proteins |
| 08/12/1999 | WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule |
| 08/12/1999 | WO1999040183A1 Human serine protease and serpin polypeptides |
| 08/12/1999 | WO1999040180A2 Expanded and genetically modified populations of human hematopoietic stem cells |